Key result
BOARD scheme guides management of coexisting PPCM and preeclampsia in a recent case report.
Why the study?
Peripartum cardiomyopathy is a rare disease with unknown cause that requires timely diagnosis and therapy to avoid adverse outcomes in pregnant and peripartum women presenting with cardiac decompensation.
Case Report (n=1)
Preeclampsia and peripartum cardiomyopathy can coexist and should be managed promptly, potentially utilizing the BOARD scheme.
Raises awareness for concurrent peripartum cardiomyopathy in preeclampsia; case-level data leaves optimal management open pending controlled studies.
Peripartum cardiomyopathy (PPCM) is a rare disease of unknown cause that affects women of childbearing age. A high index of suspicion should be maintained in the pregnant and peripartum woman who presents with sudden cardiac decompensation without any prior history of cardiac disease. The diagnosis can be confirmed with echocardiographic evidence of global left ventricular dysfunction. Timely diagnosis and institution of therapy for heart failure can avoid adverse outcomes in a parturient with PPCM. In this case report, we describe the management of primigravida presenting to the hospital's emergency department with acute cardiac failure and respiratory distress due to PPCM. The case also highlights that though preeclampsia and PPCM are two separate entities, these can coexist in the same parturient due to the common pathophysiological mechanism. In the review, the recommended medical management of heart failure in PPCM with the "BOARD" (Bromocriptine, Oral heart failure drugs, Anticoagulants, Vasorelaxing agents, and Diuretics) scheme is discussed.
No takes yet. Share an insight, caveat, or question.
Divya Sethi (2020) conducted a case report in Peripartum cardiomyopathy with preeclampsia (n=1). BOARD scheme (Bromocriptine, Oral heart failure drugs, Anticoagulants, Vasorelaxing agents, and Diuretics) was evaluated. A case report highlighting the coexistence of peripartum cardiomyopathy and preeclampsia in a primigravida, discussing management with the BOARD scheme for heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: